⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATYR News
aTyr Pharma, Inc. Common Stock
Securities Fraud Class Action Filed Against aTyr Pharma, Inc. (ATYR) - Levi & Korsinsky Reminds Investors of December 8, 2025
accessnewswire.com
ATYR
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
accessnewswire.com
ATYR
Pomerantz LLP Alerts Shareholders to Investor Suit Involving aTyr Pharma, Inc. – ATYR
accessnewswire.com
ATYR
ATYR Investors Have Opportunity to Lead aTyr Pharma, Inc. Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
ATYR
Shareholders of aTyr Pharma, Inc. (ATYR): Protect Your Rights Before December 8, 2025 - Contact Levi & Korsinsky
accessnewswire.com
ATYR
aTyr Pharma, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights - ATYR
prnewswire.com
ATYR
Levi & Korsinsky Notifies aTyr Pharma, Inc. (ATYR) Investors - Lead Plaintiff Deadline on December 8, 2025
accessnewswire.com
ATYR
ATYR Investor Alert: New aTyr Pharma, Inc. (ATYR) Securities Class Filed; Class Period Significantly Enlarged -- Hagens Berman
prnewswire.com
ATYR
Pomerantz LLP Alerts Shareholders to Investor Suit Against aTyr Pharma, Inc. – ATYR
accessnewswire.com
ATYR
aTyr Pharma Announces Third Quarter 2025 Results and Provides Corporate Update
globenewswire.com
ATYR